Drug profile · INN
ferric hexacyanoferrate(ii)
RADIOGARDASE (PRUSSIAN BLUE)
ferric hexacyanoferrate(ii) (RADIOGARDASE (PRUSSIAN BLUE)) is a radioactive metals chelating agent. Route of administration: oral. Current US regulatory status: approved.
Drug details — ferric hexacyanoferrate(ii)
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ferric hexacyanoferrate(ii) (RADIOGARDASE (PRUSSIAN BLUE)) is a radioactive metals chelating agent. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Radioactive metals chelating agent
Primary target: Radioactive metals
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ferric hexacyanoferrate(ii)?
ferric hexacyanoferrate(ii) (RADIOGARDASE (PRUSSIAN BLUE)) is a radioactive metals chelating agent. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ferric hexacyanoferrate(ii)?
RADIOGARDASE (PRUSSIAN BLUE) is a marketed brand name for ferric hexacyanoferrate(ii). Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ferric hexacyanoferrate(ii)?
ferric hexacyanoferrate(ii) has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.